반응식
CC1(C)C2C(=C(P(C3C=CC=CC=3)C3C=CC=CC=3)C=CC=2)OC2C(P(C3C=CC=CC=3)C3C=CC=CC=3)=CC=CC1=2.[CH3:43][O:44][C:45]1[CH:46]=[C:47]2[C:52](=[CH:53][CH:54]=1)[CH:51]=[N:50][C:49]([NH2:55])=[CH:48]2.Cl[C:57]1[CH:62]=[C:61]([CH2:63][N:64]2[CH2:68][CH2:67][CH2:66][CH2:65]2)[CH:60]=[CH:59][N:58]=1.C([O-])([O-])=O.[Cs+].[Cs+]>C1(C)C=CC=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd].C1COCC1>[CH3:43][O:44][C:45]1[CH:46]=[C:47]2[C:52](=[CH:53][CH:54]=1)[CH:51]=[N:50][C:49]([NH:55][C:59]1[CH:60]=[C:61]([CH2:63][N:64]3[CH2:65][CH2:66][CH2:67][CH2:68]3)[CH:62]=[CH:57][N:58]=1)=[CH:48]2참가 물질
반응물 4
생성물 1
시약·촉매·용매 3
실험 절차
Pd2(dba)3(102 mmg, 0.11 mmol) and xantphos (92 mg, 0.16 mmol) were added to a solution of 6-methoxyisoquinolin-3-amine (195 mg, 1.12 mmol) (Preparation C-10), 2-chloro-4-pyrrolidin-1-ylmethyl-pyridine (220 mg, 1.12 mmol) (Preparation B-11) and Cs2CO3 (500 mg, 1.53 mmol) in toluene (50 mL). The suspension was heated under reflux overnight, and THF (50 mL) was added in to dilute the mixture. After filtration, the filtrate was concentrated. The crude material was further purified by silica gel chromatography (EtOAc/Hexane=1/1) and afforded the title compound (150 mg, 40% yield) as a yellow solid. 1H NMR (300 MHz, DMSO-d6): 8.84 (s, 1H), 8.27˜8.29 (m, 2H), 7.73 (d, J=8.7 Hz, 1 H), 7.60 (bs, 1H), 6.99˜7.08 (m, 3H), 7.02 (s, 1H), 6.86 (d, J=5.1 Hz, 1H), 3.94 (s, 3H), 3.62 (s, 2H), 2.58 (m, 4H), 1.83 (m, 4H); MS: m/z 335.2 (M+H+).
후처리
- temperatureThe suspension was heated
- temperatureunder reflux overnight
- additionto dilute the mixture
- filtrationAfter filtration
- concentrationthe filtrate was concentrated
- customThe crude material was further purified by silica gel chromatography (EtOAc/Hexane=1/1)
출처 및 근거
- ORD 기록
- ord-3ab79e0739224c7591c18a39dc1a4aae
- 출처 데이터셋
- uspto-grants-2013_06
- 특허 번호
- US08461339B2
연결된 노트
불러오는 중…